National Institute for Health and Care Excellence8 日
Over 1,000 people with advanced breast cancer set to benefit from new once-a-day tablet
We’ve issued final draft guidance recommending a new once-a-day tablet that is set to benefit around 1,100 people with a type ...
National Institute for Health and Care Excellence8 日
Public consultation launched on changes to NICE's Highly Specialised Technologies routing ...
NICE is proposing changes to its routing criteria for Highly Specialised Technologies (HST) to ensure more consistent, ...
National Institute for Health and Care Excellence7 日
NICE recommends new treatment to prevent and reduce hearing loss in people being treated ...
Anhydrous sodium thiosulfate, also known as Pedmarqsi and made by Norgine, is recommended in final draft guidance for preventing hearing loss caused by cisplatin chemotherapy in children from the ages ...